ESC 365 - Furosemide Withdrawal in Stable Chronic Outpatients with Heart Failure: a Double-blind, Multicenter, Randomized Trial

HFA Premium Access

Furosemide Withdrawal in Stable Chronic Outpatients with Heart Failure: a Double-blind, Multicenter, Randomized Trial

Session: Late breaking trial II - Chronic heart failure

Topic: Pharmacotherapy

Speaker: Doctor A. Biolo (Porto Alegre, BR)

Event: Heart Failure 2019

Congress Presentation

Add to my library

About the speaker

Doctor Andreia Biolo

Federal University of Rio Grande do Sul, Porto Alegre (Brazil)

1 presentation

0 follower

12 more presentations in this session

Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial

Speaker: Professor M. Schulz (Leipzig, DE)

Discussion - PHARM-CHF

Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and Chronic Kidney Disease (AMBER): Results in the Prespecified Subgroup with Heart Failure

Speaker: Professor P. Rossignol (Monaco, MC)

Discussion - AMBER.

Discussion - Furosemide Withdrawal in Stable Chronic Outpatients with Heart Failure: a Double-blind, Multicenter, Randomized Trial

Access the full session

Late breaking trial II - Chronic heart failure

Speakers: Doctor A. Biolo, Professor M. Schulz, Professor P. Rossignol

About the event

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress

ESC 365 is supported by

novartis

Explore sponsored resources